Slide presentations

Displaying 1 - 386 of 386
Interactive case studies: improving clinical outcomes on invasive aspergillosis N. Singh Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Fungal infections in cancer patients G. Maschmeyer Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
Surgical infection and outbreaks M. Richardson Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Case presentation on CPA - Patient AV David Denning General
Assessment of Moisture and Mold Problems - the Finnish Example Anne Hyvärinen Indoor Air 2015
Is azole resistance increasing amongst Aspergillus species? C. Lass-Florl Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Medical Mycology in India: Past, Present & Future (Presidential address) A. Chakrabarti Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Aspergillus DNA barcoding –progress so far J. Varga et al Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Can statins be useful in invasive fungal infections? P Bergman ECCMID 23rd, Berlin. April 27-30 2013
Aspergillosis - Invasive disease in patients with leukemia J. Maertens Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
CT imaging in Aspergillus lung infections CP. Heussel European Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010
Aspergillosis in the USA, UK and Japan in 20th Century DW. Denning Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Do animal models help predict host responses to fungal infections and antifungal treatment? J. Adler-Moore ECCMID 20th Vienna, Austria, 10th-13th April, 2010
Designing new diagnostic-driven therapy concepts Johan Maertens ECCMID 24th May 10 - 13 2014, Barcelona, Spain
Neglected fungal infections of eye Ariya Chindamporn ISHAM 2015
An introduction to fungi and Aspergillus in health and disease Jenny Bartholomew General
Molecular diagnostics beyond PCR M. Sanguinetti Trends In Medical Mycology 3rd (TIMM)
The comparative genomics of Aspergilli W. Nierman Aspergillus workshop at the 7th European Conference of Fungal Genetics, Copenhagen, April 2004 (ECFG)
Which antifungal for which site of infection? David Andes Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Fungal infections in COPD W. Meersseman Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
New Antifungal Drugs in the Pipeline Prof. Sevtap Arikan-Akdagli, MD ECCMID 25th 25-28 April 2015 Copenhagen Denmark
A bird's eye view of the fungal kingdom - a quest for nomenclature stability (1) Sybren de Hoog Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Aspergillosis in breeding turkeys J. Guillot ISHAM Tokyo May 25-29 2009
Top 3 Basic Science Papers on Aspergillus fumigatus 2011 N. Osherov Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Avian aspergillosis J. Guillot ISHAM 2006 June 25-29, Paris 2006
New agents for aspergillosis: Development pathways and economic pull John H. Rex Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Fungi, fungal infections and immunity in the metagenomic era Luigina Romani ISHAM 2015
Evolving invasive fungal infections - What are the reasons and implications for the change D. Kontoyiannis ECCMID 18th Barcelona, Spain. 19-22 April 2008
Management of Aflatoxigenic Fungi in Groundnut Varieties in Central Tigray through Soil Solarization and Planting Time T. Kahsat et. al. Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Diagnostic methods to detect Aspergillus species in clinical samples using conventional and non-culture techniques Jesús Guinea Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Non-fumigatus Aspergilli Fungi that catch you out -Diagnostics and management John W. Baddley ISHAM 2015
Asthma and its phenotypes S. Wenzel Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Genome and proteomic analysis of industrial fungi SE. Baker British Mycological Society, Annual Scientific Meeting 2005. EXPLOITATION OF FUNGI , University of Manchester: September 5-8 2005 (BMS)
Optimal antifungal prophylaxis - the case for posaconazole O. Cornely Annual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009
Cryptococcus neoformans copper homeostasis machinery: Therapeutic target in fungal pathogenesis Dennis Thiele, PhD Antifungal Drug Development Summit
Optical Particle Recogntion for (Practical) Discrimination Between Bioaerosol Classes Mark Hernandez Indoor Air 2015
Fungal infections in patients with hematological malignancies: advances in diagnosis and prevention Y. Kanda ISHAM Tokyo May 25-29 2009
Visualising phagosomal killing of Aspergillus fumigatus JM. Vyas Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Ochratoxin A in profiling and speciation FJ. Cabanes Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Assessment of the Biodegradability of Containers for Low- and Intermediate-Level Nuclear Waste Borys Zlobenko Second Research Coordination Meeting of IAEA CRP:Behaviour of Cementitious Materials in Long Term Storage and Disposal of Radioactive Waste IAEA Research
Canine sino-aspergillosis parallels with human disease M. Day Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Critique of trials in ABPA and fungal allergy R. Moss Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Clinical risk factors for invasive aspergillosis J. Baddley Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Salvage therapy of invasive aspergillosis refractory to primary therapy with voriconazole Johan Maertens ECCMID 24th May 10 - 13 2014, Barcelona, Spain
FUNGAL VIRULENCE FACTORS IN OCULAR INFECTIONS Philip Thomas General
An introduction to anti-fungal pharmacology R. Lewis General
Design of clinical trials for treatment of invasive fungal infections J. Powers Trends In Medical Mycology 3rd (TIMM)
Chronic pulmonary aspergillosis DW. Denning Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
Paediatric mycoses: treatment and prophylaxis Andreas Groll Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Indoor fungi and climate change R. Samson Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Aspergillosis spectrum of disease DW. Denning Belgian Society for Mycology/ SBIMC Nov 8th, 2012
Antifungal drugs in neonates and children W. Steinbach ICAAC 47th Chicago September 17-20th 2007
Fungal-Specific Mechanisms of Ras-Mediated Morphogenetic Signaling in Aspergillus fumigatus J. Fontwendel Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Role of non culture biomarkers for detection of fungal infections Tom Rogers Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Radiology of pulmonary invasive fungal infections DL. Escuissato Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Neutrophils and damage during invasive aspergillosis: Superoxide and STAT3 S. Holland Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Non culture based diagnosis of aspergillosis C. Lass-Flörl ECCMID 21st / 27th ICC Milan 7th - 10th May , 2011
Postoperative aspergillosis AC. Pasqualotto ECCMID 16th April 1-4 2006 Nice, France
Aspergillus Speciation in the 21st Century - Implications for Laboratory and Clinical Practice Manuel Cuenca-Estrella Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Epidemiology, Prevention and Diagnosis of fungal infections in solid organ transplant Husain Shahid ISHAM 2015
Subtelomeric diversity as a major force in evolution of Aspergillus secondary metabolism and virulence pathways B. Nierman Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Combination anti-fungal therapy: current concepts, lab investigations and clinical trials T. Walsh Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Aspergillosis - who gets what, why and when? DW. Denning Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Targeting a novel phosphorylated domain in calcineuri Bill Steinbach, MD Antifungal Drug Development Summit
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) Dr Ritesh Agarwal MD, DM Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Fungal rhinosinusitis - a categorization and definitional schema DW. Denning ISHAM Tokyo May 25-29 2009
Update on resistance mechanisms: Highly active triazole antifungal agents DS. Perlin Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Five talks - powerpoint slides and audio presentations (NYAS members only) DW. Denning; K. Marr; T. Walsh; JP. Latge; G. Brown New York Academy of Sciences: Invasive aspergillosis - New approaches against a dangerous fungal infection
Influence of eicosanoid lipid mediators on macrophage innate immune functions Prof. Marc Peters-Golden HS Talks
Comparison of the two sequenced clinical isolates of A. fumigatus N. Fedorova Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Airborne fungal fragments and allergenicity B. Green Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Genetic susceptibility to Aspergillosis in allogeneic stem cell transplantation A. Carvalho Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Fungal Infections in the era of Immunobiologicals: Good, the bad and the ugly Baddley John ICAAC 2014, Washington Sep 5-9
Burden of invasive fungal infections in developing countries Arunaloke Chakrabarti Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Update on glucan detection M. Richardson Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
Role of azole concentration monitoring (TDM) in patient management Eliane Billaud Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Rational use of antibiotics: Echinocandins & Lipid formulation of amphotericin B Felipe F Tuon MD, PhD Infocus 2014
Moisture and the Indoor Microbiome Jeffrey Siegel Indoor Air 2015
Aspergillus sinusitis in paediatric case with AML (with videos) R. Migliavacca Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
How to best diagnose fungal infections Lass-Flörl ECCMID 22nd March 31 - April 3 2012, London, UK
Biodiversity of aspergillus sp. nigri from grapes in Europe G. Perrone Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Antifungal dosing and therapeutic drug monitoring A Ullmann ECCMID 23rd, Berlin. April 27-30 2013
Difference in invasive aspergillosis in solid organ transplant recipients S. Husain Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Diagnostic advances for distinct patient populations JP. Gangneux European Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010
ABPA and asthma fungal sensitisation A. Knutsen Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Aspergillus and aspergillosis: From the environment to the patient J. Guinea ECCMID 20th Vienna, Austria, 10th-13th April, 2010
T-Cells in Aspergillosis - Clinical Aspects Thomas Lehrnbecher ECCMID 24th May 10 - 13 2014, Barcelona, Spain
Current rates of resistance, impact on clinical use and prescribing of drugs Manuel Cuenca Estrella ISHAM 2015
Fungal infections in cystic fibrosis E. Castagnola Trends In Medical Mycology 3rd (TIMM)
Management of allergic aspergillosis D. Stevens Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Antifungal PK/PD made simple David Andes Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
New developments and challenges in diagnostics of invasive fungal infections? O. Marchetti Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Targeting Ras-like proteins: a novel approach for antifungal therapy Andy Alspaugh, MD Antifungal Drug Development Summit
Emerging fungal threats to animal plant and ecosystem health Matthew Fisher Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Aspergillosis in wild and captive birds in Japan T. Yanai ISHAM Tokyo May 25-29 2009
Neutrophil granulocytes in their defence against invasive aspergillosis M. Gunzer Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Filamentous fungi and chronic respiratory infections in cystic fibrosis JP. Bouchara ISHAM 2006 June 25-29, Paris 2006
Culture and sensitisation in asthma, CF and COPD – what does it tell us? Catherine Pashley Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Top Papers on Invasive Fungal Disease Management 2014-15 Souha S. Kanj, MD, FACP, FIDSA ECCMID 25th 25-28 April 2015 Copenhagen Denmark
Hospital water and invasive fungal infection P. Gaustad ECCMID 18th Barcelona, Spain. 19-22 April 2008
Impact of prophylaxis on galactomannan, ß-D-glucan and PCR JP. Donnelly Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Clinical profile of cryptic Aspergillus species David W. Denning Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Aspergillus PCR achieving standardisation Peter Donnelly ISHAM 2015
Differences in the immunobiology of Aspergillus colonization and ABPA J. Kolls Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
What can genomics tell us about secondary metabolism in Aspergillus G. Turner British Mycological Society, Annual Scientific Meeting 2005. EXPLOITATION OF FUNGI , University of Manchester: September 5-8 2005 (BMS)
Aspergillosis in AIDS DW. Denning Annual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009
Discovering molecules to probe and treat malaria Emily Derbyshire, PhD Antifungal Drug Development Summit
Quantitative PCR in Microbial Assessment of Indoor Spaces Martin Täubel Indoor Air 2015
Factors influencing the Aspergillus fumigatus survival into the host, mediated by the calcineurin pathway. G. Goldman ISHAM Tokyo May 25-29 2009
Epidemiology of Fungal Endophthalmitis N. Nayak Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Experience from the yeast database V. Robert Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Breakpoints and epidemiological cutoff values (BPs and ECVs): Can they predict clinical response? Ana Espinel-Ingroff, MS,PHD ISHAM 2015
Controversies surrounding categorization of fungal sinusitis A. Chakrabarti Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Treatment of invasive aspergillosis: Polyenes, azoles, echinocandins? T. Patterson Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
NADPH oxidase: regulator of host defense and inflammation (CGD) B. Segal Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
First-line therapy with combined antifungal for aspergillosis Raoul Herbrecht ECCMID 24th May 10 - 13 2014, Barcelona, Spain
Factors influencing the outcome of therapeutic penetrating keratoplasty for mycotic & supparative keratitis Thomas et al ISHAM 2015
Alkaptonuria and Aspergillus nidulans M. Penalva General
Combination antifungal therapy J. Edwards Trends In Medical Mycology 3rd (TIMM)
What the Aspergillus genomes have told us W. Nierman Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
Solid organ transplant patients Jose Aguado Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Educational resources on the internet M. Richardson & P. Donnelly Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Treatment guidelines for invasive aspergillosis T. Patterson ICAAC 47th Chicago September 17-20th 2007
Burden and distinctive character of ABPA in India R. Agarwal Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
The role of lymphocytes & IFD in the transplant setting Andrew Ullman Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Galactomannan testing: lessons from the last decade C. Viscoli Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Conventional or molecular measurement of Aspergillus load K. Clemons Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Is pre-emptive therapy a realistic approach? JP. Donnelly ECCMID 21st / 27th ICC Milan 7th - 10th May , 2011
Current recommendations for the prevention of nosocomial infection: are they applicable to moulds? R. Barnes ECCMID 16th April 1-4 2006 Nice, France
Epidemiology of infections by cryptic species of Aspergillus Jan W.M. van der Linden Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
ABPA in Cystic Fibrosis: How is it Different from ABPA in Asthma? Richard Moss ISHAM 2015
Aspergillus and biotechnology S. Baker Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Getting to the diagnosis of aspergillosis-tests and their interpretation DW. Denning Anglo-Celtic debate, Dublin 2005, sponsored by Pfizer
Imaging findings in neutropenic vs. non- neutropenic patients C. Heussel Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Identification and characterization of novel antifungal small molecules Damian Krysan, MD, PhD Antifungal Drug Development Summit
CLSI update Mahmoud Channoum Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Filamentous fungal infections and the role of amphotericin B DW. Denning ISHAM Tokyo May 25-29 2009
Immune regulation in idiopathic bronchiectasis R. Boyton Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
het-genes in Aspergillus niger K. Pal Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
O-GlcNAc, an essential regulator of numerous cellular pathways Dr. Natasha Zachara HS Talks
MLST versus Microsatellites C. Klaassen Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
The impact of environmental fungi on housing and building design M. Chapman Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Newer combination therapies W. Steinbach Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Top 10 Mycology papers Patterson T and Konoyiannis D (presenters) and many others ICAAC 2014, Washington Sep 5-9
Cystic fibrosis and moulds Giraud, Symoens & Bouchara ISHAM 2015
The changing epidemiology of invasive aspergillosis W Meersseman Belgian Society for Mycology/ SBIMC Nov 8th, 2012
Toll-like receptors: recent advances, open questions and implications for aspergillosis control F. Ebel Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Primary diagnostic approaches - molecular testing S. Bretagne Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Antifungal Antimicrobial Stewardship: Reduced Costs and Improved Care. Rational Use of Triazoles Vivian M. Carvalho Hessel Dias Infocus 2014
Revolution/Evolution - DNA Sequencing To Identify Indoor Air Microorganisms Jordan Peccia Indoor Air 2015
Antifungal Pharmacodynamics - A strategy to Optimize Efficacy D. Andes Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Research priorities in Medical Mycology DW. Denning ECCMID 22nd March 31 - April 3 2012, London, UK
Mating type and species recognition in the aspergilli P. Dyer Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Fungal epidemiology in CF patients & overview of EUCAST breakpoints C Laas-Florl ECCMID 23rd, Berlin. April 27-30 2013
Can we rely on imaging and biomarkers for pre-emptive antifungal therapy in hematological patients? C. Viscoli Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Invasive aspergillosis in steroid-treated patients D. Kontoyiannis Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Managing chronic pulmonary aspergillosis- Recent results with Voriconazole J. Cadranel European Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010
Invasive aspergillosis in critically Ill patients. A new 21th century problem? K. Vandewoude Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Clinical impact of the Blood levels of azoles O. Marchetti ECCMID 20th Vienna, Austria, 10th-13th April, 2010
Fighting against fungal infections: cells on the front lines Emmanuel Roilides ECCMID 24th May 10 - 13 2014, Barcelona, Spain
Mycopia: Fungal Allies & Fungal Adversaries Sarah Gurr ISHAM 2015
Fungal infections in COPD W. Meersseman Trends In Medical Mycology 3rd (TIMM)
Management of invasive aspergillosis DW. Denning Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
A bird's eye view of the fungal kingdom- changing species names (2) Sybren de Hoog Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
PCR-where have we gone? M. Cuenca-Estrella Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
History and chemical diversity of the echinocandin lipopeptide antifungal metabolites Gerald Bills, PhD Antifungal Drug Development Summit
News from EUCAST Maiken Cavling Arendrup Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Aspergillosis of the dog and cat R. Kano ISHAM Tokyo May 25-29 2009
Management of chronic pulmonary aspergillosis K. Izumikawa Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Galactomannan - Role in pre-emptive therapy J. Maertens ICAAC 2006 Sept 27-30, San Francisco
Targetting Aspergillus fumigatus virulence factors in a mouse model of corneal infection E. Pearlman Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Fungal Outbreaks Dr. Shawn Lockhart and Dr. Patricia Muñoz ECCMID 25th 25-28 April 2015 Copenhagen Denmark
Multi-resistant aspergillosis due to cryptic species Susan Howard Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Pharmacologic Principles andClinical Evidence forthe Managementof IFDs and Mucormycosis Michelle Ananda-Rajah ISHAM 2015
Cerebral aspergillosis: Tissue penetration is the key S. Schwartz Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Invasive aspergillosis : Update on conventional diagnosis J. Bille Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
Amphotericin- or echinocandin-based antifungal prophylaxis approaches J. Young Annual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009
A Novel Arylamidine Antifungal Drug, T-2307 Yoshiko Fukuda, PhD Antifungal Drug Development Summit
Main Principles for Bioaerosol Sampling and Analysis Tiina Reponen Indoor Air 2015
Transcription profiling of A fumigatus laeA in the murine lung W. Nierman ISHAM Tokyo May 25-29 2009
Invasive Aspergillosis in India: Unique Challenges R. Soman Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Genetic diversity in A. flavus (S & L) K. Ehrlich Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Update on Job's (Hyper IgE) Syndrome: the many paths of STAT3 A Freeman ICAAC, 53rd, Denver September 10-13 2013
Chitin synthases of aspergilli: functions of tip growth and morphogenesis in aspergillus nidulans H. Horiuchi Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Managing drug interactions in the patient with aspergillosis RE. Lewis Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Azole resistance in Aspergillus– is it a problem? S. Howard Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Therapeutic monitoring of drug levels for invasive aspergillosis Susan Howard ECCMID 24th May 10 - 13 2014, Barcelona, Spain
Isavuconazole: spectrum of activity George Thompson ISHAM 2015
The Fungal Kingdom - diverse and essential roles in earth's ecosystem (A REPORT FROM THE AMERICAN ACADEMY OF MICROBIOLOGY) M. Buckley General
Aspergillus in the non-neutropenic host J. Garbino Trends In Medical Mycology 3rd (TIMM)
Advances in the diagnosis of invasive Aspergillosis P. Verweij Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
Risk assessment in the Haemato-Oncologic patient Martin Hoenigl Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
The association between environment and fungal disease M. Richardson Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
How to define response in clinical trials? B. Pauw ECCMID 18th Barcelona, Spain. 19-22 April 2008
Emerging clinical associations with aspergillosis: COPD and aspergillosis J. Guinea Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Chronic pulmonary aspergillosis (CPA) in association with tuberculosis and AIDS I. Page Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
Risk assessment in the hemato-onco patient Markus Ruhnke Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Classical Mycology - We still need the basics P. Godoy Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Proteome analysis for pathogenicity and new diagnostic markers O. Kniemeyer Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Pulmonary aspergillosis: pathogenesis and treatment DW. Denning International Union of Microbiological Societies 2011( IUMS) Mycology 6-10th Sept
In vivo response in a mixed infection model of azole susceptible and resistant Aspergillus spp. strains Laura Alcazar-Fuoli Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Aspergillus resistance Don Sheppard ISHAM 2015
Clinical trial design for mould–active agents: Time to break the mold E. Anaissie Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Latest developments in the treament of invasive aspergillosis W. Steinbach Anglo-Celtic debate, Dublin 2005, sponsored by Pfizer
Epidemiology and surveillance of fungal infections: an overview D. Warnock Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Antifungal drug combinations Gerry Wright, PhD Antifungal Drug Development Summit
QC of fungi Paul E Verweij MD Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Fungal infections in non-neutropenic patients - CPA K. Izumikawa ISHAM Tokyo May 25-29 2009
Global status of azole resistance in Europe and Asia S. Arikan-Akdagli Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Species delimitation in Aspergillus section fumigatus based on polyphasic taxonomy SB. Hong Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Infection in the cystic fibrosis lung Dr. Stuart Elborn HS Talks
The species concept in Aspergillus: recommendations of an international workshop R. Samson Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Invasive aspergillosis: Elucidation of genetic risk factors for disease A. Zaas Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
TB and the rising tide of chronic pulmonary aspergillosis DW. Denning Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Infection Risk Modeling in Solid Organ Transplantation: The Fungal Problems Shahid Husain ICAAC 2014, Washington Sep 5-9
Filamentous fungi MALDI-TOF identification Stéphane Ranque ISHAM 2015
Pneumonia in a presumed immunocompetent patient M Bruyneel and D Konopnicki Belgian Society for Mycology/ SBIMC Nov 8th, 2012
Epidemiology of invasive fungal infections in children T. Zaoutis ICAAC 47th Chicago September 17-20th 2007
Fungal airway infection and proteinase-dependent atopy and asthma: an emerging paradigm D. Corry Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Integration of host genomics into infectious risk in AML patients: challenges and opportunities Samuel Shelburne ICAAC 2014, Washington Sep 5-9
Molecular Tools & Microbial Ecology of Buildings - A Practitioner's View Miia Pitkäranta Indoor Air 2015
Diagnosis of Fungemia using Molecular Methods A. Salles Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Direct detection of resistance in clinical specimens C. Klaassen ECCMID 22nd March 31 - April 3 2012, London, UK
The importance of aspergilli in biotechnology P. Dijck Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Global epidemiology on fungal infections: The burden of diseases Sevtap Arikan ECCMID 23rd, Berlin. April 27-30 2013
Monitoring antifungal treatment response in neutropenic patient with aspergillosis CA. Cunha Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandin drugs T. Hohl Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Infection control measures for cancer patients undergoing treatment: prevention of fungal infections in neutropenic patients P. Gastmeier ECCMID 21st / 27th ICC Milan 7th - 10th May , 2011
Aspergillus fumigatus - Growth and virulence J. Rhodes Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Antifungal susceptibility testing. Which method and when? JL. Rodriguez-Tudela ECCMID 20th Vienna, Austria, 10th-13th April, 2010
Visual session of unusual Aspergillus species: images and plates J. Varga, S. Kocsubé, G. Szigeti, N. Baranyi, J. Houbraken, R. A. Samson Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Can we agree on grading? Oliver Cornely ISHAM 2015
Interaction of Aspergillus with human respiratory mucosa R. Amitani Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
What beneficial role may the laboratory play involving aspergillosis - isolation, identification, serologic diagnoses, susceptibility testing, epidemiology? D. Kontoyiannis Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
In vitro cross-resistance between azoles in Aspergillus fumigatus: a reason for concern in the clinic? E. Mellado Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Discovery of natural products that potentiate the activity of current antifungal drugs Ameeta Agarwal, PhD Antifungal Drug Development Summit
Commercial tests Joseph Meletiadis PhD Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Pharmacokinetics of antifungal agents in pediatric patients A. Groll ISHAM Tokyo May 25-29 2009
Regulation of cellular morphogenesis during development in Aspergillus nidulans SD. Harris Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Chronic pulmonary aspergillosis DW. Denning ICAAC 2006 Sept 27-30, San Francisco
Prophylaxis limitations: Challenges in the management of invasive aspergillosis P. Chandrasekar Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Whole genome comparison of A. fumigatus group J. Wortman Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Study of antifungal resistance mechanisms in cryptic species Emilia Mellado Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Aspergillus PCR achieving standardisation Peter Donnelly
Sick building syndrome: Is mould the cause? A. Terr Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
History of Medical Mycology in Germany M. Ruhnke Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
Optimal Prophylaxis: Case for Fluconazole/ Itraconazole P.H. Chandrasekar Annual Meeting of the Infectious Diseases Society of America 47th (IDSA) Oct 29th-Nov 1st 2009
New antifungal development: What are the needs and do we have the answers? John Perfect MD Antifungal Drug Development Summit
Microbial Sampling in Building Surveys - What and Why are We Sampling Maria Nunez Indoor Air 2015
Differential diagnosis of rhinosinusitis H. Saleh British Society for Allergy & Clinical Immunology June 29th - 1st July (BSACI)
Pro Management Guidelines of Invasive Fungal Infections OA. Cornely Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
Aflatoxin biosynthesis and regulation K. Ehrlich Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Prevention of Fungal Infections: What is the Evidence for Antifungals? S Husain ICAAC, 53rd, Denver September 10-13 2013
Sexual structures in Aspergillus- morphology importance and genomics D. Geiser Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Diagnosis and management of fungal allergy A. Knutsen ICAAC 50th Boston 12th-15th September, 2010
AFRS: Current approaches to postoperative management B. Marple Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Alternative models for studying Aspergilli P. Warn Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Persistent febrile neutropenia: diagnostic-driven antifungal therapy vs. empirical antifungal therapy Manuela Aguilar-Guisado ECCMID 24th May 10 - 13 2014, Barcelona, Spain
Global burden of fungal diseases David Denning ISHAM 2015
Fungal keratitis in man A. Tullo General
Invasive mycoses in the brain L. Pagano Trends In Medical Mycology 3rd (TIMM)
The evolution of Aspergillus species D. Geiser Aspergillus workshop at the 7th European Conference of Fungal Genetics, Copenhagen, April 2004 (ECFG)
Risk assessment in the ICU patient Sergio Ruiz-Santana Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Intrapulmonary drug distribution & pharmacodynamic interactions of antifungal drugs with host cells RE. Lewis Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
The role of fungi in respiratory allergies DW. Denning British Mycological Society, 6-8 April 2009 (BMS)
Update on biologicals for ABPA and asthma RB. Moss Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Diagnosis of pulmonary aspergillosis DW. Denning ISHAM 2006 June 25-29, Paris 2006
Prevention of invasive fungal infections in solid organ transplant recipients: Universal or Targeted Prophylaxis? P. Grossi Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Immune reconstitution syndrome in immunosuppressed hosts with opportunistic infections N. Singh ECCMID 18th Barcelona, Spain. 19-22 April 2008
CPA new treatment evidence and emergence of azole resisitant A. fumigatus in Japan K. Izumikawa International Union of Microbiological Societies 2011( IUMS) Mycology 6-10th Sept
Current classification of the clinically relevant Aspergillus species complexes Cornelia Lass-Flörl Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Aspergillosis in Companion Animals - fungal rhinosinusitis Vanessa Barrs ISHAM 2015
Mechanisms behind the CF-ABPA link D. Harti Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
The importance of early appropriate therapy of invasive aspergillosis H. Boucher Anglo-Celtic debate, Dublin 2005, sponsored by Pfizer
Surgical treatment: for whom and when? G. Massard Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Chemical genomics-based antifungal drug discovery Terry Roemer PhD Antifungal Drug Development Summit
ECMM external quality control programs in mycology Dr Elizabeth Johnson, Dr Paul Verweij Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Animal models in preclinical trials of aspergillosis K. Clemons ISHAM Tokyo May 25-29 2009
Top 3 Papers in Aspergillosis for Clinical Sciences M. Akova Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Genome sequencing and analysis of the versatile cell factory Aspergillus niger N. Peij Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Innate-like B cells Prof. John F. Kearney HS Talks
Antifungal treatment of severe asthma DW. Denning Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
PCR -platforms strengths and weaknesses L. White Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Invasive aspergillosis in acute leukaemias M. Caira Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Modeling to Assess Antifungal Treatment Strategies in High Risk Patients: Haematological Malignancies Russell Lewis ICAAC 2014, Washington Sep 5-9
What Can We Learn From Immunodeficiency Syndromes About Treating IFI Michail Lionakis ISHAM 2015
Invasive Aspergillosis in Allogeneic stem cell transplantation (ASID 2005) K. Singh General
Clinical relevance of resistance in Aspergillus DW. Denning ICAAC 47th Chicago September 17-20th 2007
Paediatric aspergillosis: New findings and unique aspects W. Steinbach Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
The antifungal landscape: looking forward John Rex Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Transplant recipients with fungal infections: How do we effectively use the clinical microbiology lab Hanson Kimberley ICAAC 2014, Washington Sep 5-9
Indoor molds and fungal rhinosinusites; Can we improve detection of fungi from the sinuses? Valentina Arsić Arsenijević Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Discussion and analysis of the major trials in invasive aspergillosis DW. Denning Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Maldi-Tof in the clinical route M. Sanguinetti ECCMID 22nd March 31 - April 3 2012, London, UK
Regulatory aspects of aspergillus nomenclature P. Dijck Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
New generation sequencing any use? Stephane Bretagne Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Invasive aspergillosis in patients taking steroids A. Pasqualotto Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Stage-specific Innate Immune Recognition of Aspergillus fumigatus and Modulation by Echinocandin Drugs T. Hohl Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Application of PK/PD concepts and the role of TDM in the management of patients with fungal disease. The role of combination therapy as of May 2011 C. Viscoli ECCMID 21st / 27th ICC Milan 7th - 10th May , 2011
Global control of Aspergillus fumigatus toxins N. Keller Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Aspergillus resistance mechanisms, susceptibility testing and breakpoints M. Arendrup ECCMID 20th Vienna, Austria, 10th-13th April, 2010
Diagnosis and treatment of invasive aspergillosis — Are we doing it well? Patricia Muñoz Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Pharmacokinetic and pharmacodynamic considerations for pediatric antifungal dosing William Hope ISHAM 2015
Biofilm formation by Aspergillus G. Ramage Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Treatment of invasive mycoses in the European Community: Contrasts and comparisons with American clinical practice P. Verweij Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Prophylaxis, empirical, pre-emptive therapy of aspergillosis in hematological patients: which strategy? G. Maschmeyer Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
The fungal Achilles Heel: Targeting Hsp90 to cripple fungal pathogens Leah Cowen, PhD Antifungal Drug Development Summit
How do I treat Invasive Fungal Infections? Aspergillosis Andrew J. Ullmann, M.D. Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Antifungal therapy for children A. Groll ISHAM Tokyo May 25-29 2009
Controversies in management: prophylaxis or diagnostics. Caveats in the use of biological markers for early diagnosis DE. Karageorgopoulos Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Early diagnosis and pre-emptive therapy of fungal pneumonia in high risk patients: Current thinking K. Marr ICAAC 2006 Sept 27-30, San Francisco
Host response signatures to invasive aspergillosis T. Zelante Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
What's new in the Aspergillus niger genome? S. Baker Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Detection of fungal infections with radiolabelled antifungal agents A. Lupetti Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
In vitro antifungal susceptibility of cryptic Aspergillus species Ana Alastruey Izquierdo Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Aspergillus galactomannan & PCR in perspective for haematology patients Dr. Orla Morrissey ISHAM 2015
Role of (1-3)-beta-D-glucan in the diagnosis of Invasive Aspergillosis F. Marty Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Update on antigen detection P. Verweij Trends in Medical Mycology 2nd, Berlin, October 2005 (TIMM)
Epidemiology and outcomes of IA in the 21st Century: Strengths and weaknesses of surveillance databases D. Neofytos Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Antifungal Drug Development Summit (2015) Playlist All Antifungal Drug Development Summit
Microbila Growth and Interactions on Indoor Surfaces - Microbila Secondary Metabolites and Mycotoxins Kristian F. Nielsen Indoor Air 2015
Concepts in rhinosinusitis N. Jones British Society for Allergy & Clinical Immunology June 29th - 1st July (BSACI)
Treatment of invasive aspergillosis DW. Denning Society for Indian Human & Animal Mycologists 9th (SIHAM), Siliguri, India. Feb 10th-12th 2012
New taxa in the Aspergillus genus J. Varga et al Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
ICAAC 2013 Top 10 Papers in Mycology T. Patterson ICAAC, 53rd, Denver September 10-13 2013
Diagnostic imaging in experimental invasive pulmonary aspergillosis T. Walsh Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
The spectrum of aspergillosis DW. Denning European Respiratory Society (ERS) Advances in the understanding of Aspergillosis 18th-22nd September, 2010
Allergen genomics P. Bowyer Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Aspergillus: nosocomial or community acquired? P. Vanhems Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Innate immunity and infections in transplant patients - new insights José M. Aguado ECCMID 24th May 10 - 13 2014, Barcelona, Spain
Controlling cereal diseases: progress and challenges Robert Park ISHAM 2015
The extraordinary spectrum of diseases caused by Aspergillus DW. Denning General
New immunosuppressive agents as risk factors for fungal infections G. Maschmeyer Trends In Medical Mycology 3rd (TIMM)
Microtubules and polarized growth in Aspergillus nidulans R. Fischer Aspergillus workshop at the 7th European Conference of Fungal Genetics, Copenhagen, April 2004 (ECFG)
Direct detection of resistance :candins vs azoles David Perlin Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Invasive mycoses in cystic fibrosis and lung transplant E. Castagnola Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Sick building syndrome B. Crook British Mycological Society, 6-8 April 2009 (BMS)
Pre-emptive vs. empirical treatment O. Uzun Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Aspergillus sinusitis DW. Denning ISHAM 2006 June 25-29, Paris 2006
Management of confirmed aspergillosis O. Cornely ECCMID 18th Barcelona, Spain. 19-22 April 2008
A. oryzae is good at usage of hydrolysing enzyme on solid surfaces Abe & Takahashi International Union of Microbiological Societies 2011( IUMS) Mycology 6-10th Sept
Introduction to workshop Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
Antifungal drug use in children: a regulatory perspective Brian Fisher ISHAM 2015
Regulation of immunity in bronchiectasis and ABPA R. Boyton Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
The use of RNAi to suppress gene function in industrial fungi NS. Dunn-Coleman British Mycological Society, Annual Scientific Meeting 2005. EXPLOITATION OF FUNGI , University of Manchester: September 5-8 2005 (BMS)
Primary immunodeficiencies and fungal infections A. Warris Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Discovery of novel antifungal drug targets Yong-Sun Bahn PhD Antifungal Drug Development Summit
Sloan Symposium Conference Workshop Indoor Air 2015
Should we monitor plasma levels of antifungal agents? D. Andes ISHAM Tokyo May 25-29 2009
Is pre-emptive therapy a realistic approach? JP. Donnelly Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Dynamics of dsRNA mycoviruses in black Aspergillus populations A. Diepeningen Aspergillus systematics in the genomics era: CBS Fungal biodiversity Centre, Utrecht, the Netherlands from 12-14 April 2007
Aspergillosis infections and the lung Prof. Rosemary Barnes HS Talks
Allergic fungal sinusitis M. Schubert Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Status of susceptibility testing in Aspergillus C. Lass-Flörl Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Aspergillosis in transplant patients F. Saliba Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Oxygen and Invasive Aspergillosis Robert Cramer ICAAC 2014, Washington Sep 5-9
Environmental Epidemiology and Prevention of Mould Infection Jan Patterson ISHAM 2015
Lipid Amphotericin B formulations and Echinocandins R. Lewis General
New immunomodulators and invasive fungal infections JH. Young & DP. Kontoyiannis ICAAC 47th Chicago September 17-20th 2007
Microscopic Observation and culture of Aspergillus species: The traditional way N. McClenny Advances Against Aspergillosis, 1st (AAA) September 2004, San Francisco
Fungal Biomarkers B Sendid & O Marchetti Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
Voriconazole vs itraconazole for primary prophylaxis of invasive fungal infection (IFI) in allogeneic hematopoietic cell transplant (HCT) recipients D. Marks Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
Indoor fungal exposure and disease Malcolm Richardson PhD, FRSB, FISSE, FRCPath Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
First line therapy for IA C. Viscoli Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Invasive aspergillosis in the ICU D. Vogelaers Belgian Society for Mycology/ SBIMC Nov 8th, 2012
Detecting and defining resistance P. Verweij ICAAC 47th Chicago September 17-20th 2007
Agricultural triazole fungicides should be withdrawn K. Lagrou Advances Against Aspergillosis/AAA - 6th 27th Feb - 1st Mar 2014 - Main presentations
The global fungal burden David Denning Trends in Medical Mycology, 6th, Copenhagen, Denmark, October 11-14 2013
What are we looking at? Challenges in the diagnosis of invasive mould diseases A. Pasqualotto Infocus VIII Forum de Infeccoes Fungicas na Pratica Clinica Aug 20 -22 2009
Granulocyte products act as alarmins to enhance innate and adaptive immunity D. Yang Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Invasive fungal infections in our hospitals today O. Lortholary ECCMID 21st / 27th ICC Milan 7th - 10th May , 2011
Infections in non-myeloablative « Reduced intensity conditioning » stem cell transplant C. Cordonnier ECCMID 16th April 1-4 2006 Nice, France
Treatment of infections by crypic Aspergillus species Alessandro C. Pasqualotto Advances Against Aspergillosis/AAA 6th - 27th Feb - 1st Mar 2014 - Workshop slides
MYCAFRICA - A network to promote Medical Mycology in Africa Mushi, Grob et al ISHAM 2015
What do we know about the role of gliotoxin in pathobiology of Aspergillus J. Kwong-Chung Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
The hodge-podge of azole antimyotics: Prudent choices and uses J. Perfect Focus on Fungal Infections 14 meeting, New Orleans, March 2004 (FFI)
Therapeutic drug monitoring in antifungal therapy,why, when and how? R. Brüggemann Trends in Medical Mycology 4th, Athens, Greece, Oct 18th-21st 2009 (TIMM)
The discovery of new, orally-active inhibitors of ß-1,3-glucan synthesis as anti-fungal agents Mike Peel, PhD Antifungal Drug Development Summit
Allergic and chronic aspergillosis: lessons for the busy mycologist: Sinusitis Helen Sambatakou Trends in Medical Mycology, 7th. Lisbon, Portugal, October 2015 (TIMM)
Are fungi responsible for chronic sinusitis? A. Chakrabarti ISHAM Tokyo May 25-29 2009
Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis R. Ben-Ami Advances against Aspergillosis 5th (AAA), Istanbul, Turkey. Jan 26-28th 2012
Aspergillosis: New risk groups MC. Arendrup ICAAC 2006 Sept 27-30, San Francisco
Cultivated anti-Aspergillus TH1 Cells T. Lehrnbecher Advances against Aspergillosis 3rd Miami USA. January 16-19 2008
Whole genome comparison of A. flavus and A. oryzae G. Payne Advances Against Aspergillosis 2nd (AAA) February 22-25, 2006 Athens, Greece
Aspergillus Endocarditis J. McCormack Advances against Aspergillosis 4th (AAA), Rome, Italy. Feb 4-6th 2010
Fungal Biomarkers in Transplantation Hanson Kimberley ICAAC 2014, Washington Sep 5-9